The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (93.16) USD. With the latest stock price at 1.16 USD, the upside of FibroGen Inc based on DCF is -8131.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 6.1% - 10.1% | 8.1% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (341.42) - (55.30) | (93.16) |
Upside | -29533.0% - -4867.0% | -8131.0% |